Herbert Conrad

Herbert Conrad

Director/Board Member at CELLDEX THERAPEUTICS, INC.

Net worth: 80 555 $ as of 31/05/2026

93 year
Health Technology
Commercial Services
Health Services

Profile

Herbert J.
Conrad
was the founder of Matinas BioPharma Holdings, Inc. (2013) as an Independent Director.
Mr. Conrad is also the founder of Reliant Pharmaceuticals LLC.
Mr. Conrad is currently an Independent Director at Celldex Therapeutics, Inc. since 2008.
Former positions include Chairman at Bone Care International, Inc., Chairman at GenVec, Inc. (1996-2003), Chairman at Sapphire Therapeutics, Inc. (2005-2009), Chairman at Matinas BioPharma, Inc. (2012-2022), Director at Savient Pharmaceuticals, Inc., Director at Dura Pharmaceuticals, Inc., Director at UroCor, Inc., Director at AVANT Immunotherapeutics, Inc. (2008), Director at SICOR, Inc., President & Director at Roche Pharmaceuticals, Inc. (1982-1993), Director at Pharmasset, Inc. (2008-2011), Independent Director at Arbutus Biopharma Corp., Director at Symphony Evolution, Inc. (2005-2009), Director at Gensia Sicor Pharmaceuticals, Inc., Director at Celldex Research Corp., and President-US Pharmaceuticals Division at F.
Hoffmann-La Roche Ltd. (1982-1993).
Education includes undergraduate and graduate degrees from Arnold & Marie Schwartz College of Pharmacy & Health Science.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
10/04/2026 2,563 ( 0% ) 80 555 $ 31/05/2026

Herbert Conrad active positions

CompaniesPositionStart
CELLDEX THERAPEUTICS, INC. Director/Board Member 01/03/2008

Former positions of Herbert Conrad

CompaniesPositionEnd
MATINAS BIOPHARMA HOLDINGS, INC. Founder 06/02/2025
Matinas BioPharma, Inc.
Chairman 01/10/2022
Chairman 01/02/2009
Director/Board Member 01/01/2009
Director/Board Member 01/10/2008
See the detail of Herbert Conrad's experience

Training of Herbert Conrad

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

54

1st degree connections

20

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies20

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Matinas BioPharma, Inc.

Health Technology

Health Technology

Gensia Sicor Pharmaceuticals, Inc.

Health Technology

Commercial Services

Consumer Services

  1. Stock Market
  2. Insiders
  3. Herbert Conrad
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!